{"nctId":"NCT04371536","briefTitle":"Oral Iron Versus Oral Iron Plus a Web-based Behavioral Intervention in Young Children (IRONCHILD)","startDateStruct":{"date":"2021-07-09","type":"ACTUAL"},"conditions":["Iron Deficiency Anemia","Iron-deficiency"],"count":1,"armGroups":[{"label":"Arm A: Oral iron therapy","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Ferrous Sulfate"]},{"label":"Arm B: Oral iron therapy plus IRONCHILD web-based intervention","type":"EXPERIMENTAL","interventionNames":["Drug: Ferrous Sulfate","Behavioral: IRONCHILD"]}],"interventions":[{"name":"Ferrous Sulfate","otherNames":["Feosol","Fer-Iron"]},{"name":"IRONCHILD","otherNames":["Web-based intervention"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n1. Age greater than or equal to 12 months to less than 48 months\n2. Iron deficiency anemia (IDA) confirmed by hematologic indices and iron laboratory parameters\\*\n\n   * Hgb between greater than or equal to 6 g/dL AND less than or equal to 10 g/dL\n   * MCV less than or equal to 70 fl\n   * Ferritin less than or equal to 15 ng/mL OR TIBC greater than or equal to 425 microgram/dL \\*CBC indices must be performed with 7 days of study enrollment. Iron indices must be performed within 30 days of study enrollment.\n3. Clinical history consistent with nutritional IDA such as prolonged breastfeeding without adequate iron supplementation or excessive milk intake (cow milk, almond milk, soy milk, goat milk or other milk, excluding breastmilk), defined as greater than or equal to 3 cups (24 ounces)per day\n4. Primary language of English or Spanish\n5. Access to smartphone with data plan and/or other internet access (i.e. home computer)\n\nExclusion Criteria:\n\n1. Iron deficiency likely or definitely due to blood loss from the intestine or other sites.\n2. Administration of a blood transfusion\n3. History or evidence of intestinal malabsorption\n4. History of prior intravenous iron therapy\n5. Major co-morbidity such as a serious chronic medical condition unrelated to iron deficiency apparent on history, physical examination, or laboratory tests\n6. Other cause of anemia (sickle cell disease, thalassemia, bone marrow failure, etc.) apparent by history, physical examination, and/or laboratory tests.\n7. Inability to tolerate oral medications\n8. Other medical or social factors at discretion of treating physician","healthyVolunteers":false,"sex":"ALL","minimumAge":"12 Months","maximumAge":"48 Months","stdAges":["CHILD"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Percentage of Eligible Patients Enrolled","description":"We hypothesized that 50% or more of eligible patients would enroll the study.","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]}]},{"type":"PRIMARY","title":"Percentage of Enrolled Subjects Who Agree With Randomization","description":"We hypothesized that randomization would be feasible, defined as agreement with randomization in greater than or equal to 80% of enrolled subjects per arm.","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":1},"commonTop":["Emesis, Constipation"]}}}